Arbutus biopharma and barinthus bio present preliminary data from phase 2a clinical trial combining imdusiran with vtp-300 at aasld - the liver meeting®

The combination of imdusiran and vtp-300 provides a meaningful reduction of hbsag levels that are maintained well below baseline

ABUS Ratings Summary

ABUS Quant Ranking